BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.87B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$2.2B |
| 3 |
Amazon
AMZN
|
+$1.9B |
| 4 |
NVIDIA
NVDA
|
+$1.86B |
| 5 |
Costco
COST
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.53B |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$1.81B |
| 3 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$732M |
| 4 |
Super Micro Computer
SMCI
|
+$728M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.8% |
| 2 | Healthcare | 12.59% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Ginkgo Bioworks
DNA
$488M
| $84.5M | ﹤0.01% |
1,821,552
+1,680
| +0.1% | +$87K |
|
2152
TriMas Corp
TRS
$1.39B
| $84.5M | ﹤0.01% |
3,159,834
+24,739
| +0.8% | +$618K |
|
2153
HSBC
HSBC
$358B
| $84.3M | ﹤0.01% |
2,142,873
+3,081
| +0.1% | +$120K |
|
2154
ADT
ADT
$5.46B
| $84.2M | ﹤0.01% |
12,533,442
+1,455,467
| +13% | +$9.67M |
|
2155
Weis Markets
WMK
$1.77B
| $84M | ﹤0.01% |
1,303,800
-54,635
| -4% | -$3.42M |
|
|
EVRI
2156
DELISTED
Everi Holdings
EVRI
| $83.9M | ﹤0.01% |
8,349,023
+59,892
| +0.7% | +$620K |
|
2157
Star Bulk Carriers
SBLK
$3.21B
| $83.9M | ﹤0.01% |
3,514,252
+1,957,065
| +126% | +$44.4M |
|
2158
MacroGenics
MGNX
$259M
| $83.8M | ﹤0.01% |
5,696,194
-444,155
| -7% | -$6.71M |
|
|
GOGL
2159
DELISTED
Golden Ocean Group
GOGL
| $83.8M | ﹤0.01% |
6,465,793
-514,831
| -7% | -$5.92M |
|
2160
iShares China Large-Cap ETF
FXI
$4.16B
| $83.5M | ﹤0.01% |
3,470,625
-6,283,516
| -64% | -$145M |
|
2161
Schneider National
SNDR
$6.37B
| $83.5M | ﹤0.01% |
3,687,140
-66,876
| -2% | -$1.59M |
|
2162
iQIYI
IQ
$1.31B
| $83.3M | ﹤0.01% |
19,692,328
+193,077
| +1% | +$742K |
|
|
THR
2163
DELISTED
Thermon Group Holdings
THR
| $83.2M | ﹤0.01% |
2,544,106
-208,822
| -8% | -$6.13M |
|
|
DAWN
2164
DELISTED
Day One Biopharmaceuticals
DAWN
| $83.1M | ﹤0.01% |
5,031,435
-94,636
| -2% | -$1.42M |
|
2165
Blue Bird Corp
BLBD
$2.05B
| $83.1M | ﹤0.01% |
2,167,222
+303,328
| +16% | +$9.29M |
|
2166
Perimeter Solutions
PRM
$5.53B
| $83M | ﹤0.01% |
11,186,372
-420,192
| -4% | -$2.26M |
|
2167
Alpha and Omega Semiconductor
AOSL
$916M
| $82.8M | ﹤0.01% |
3,757,502
-59,882
| -2% | -$1.45M |
|
2168
Kiniksa Pharmaceuticals
KNSA
$6.07B
| $82.7M | ﹤0.01% |
4,193,907
+1,013,319
| +32% | +$19.8M |
|
|
MRC
2169
DELISTED
MRC Global
MRC
| $82.1M | ﹤0.01% |
6,530,836
-30,141
| -0.5% | -$341K |
|
2170
DHT Holdings
DHT
$3.09B
| $81.3M | ﹤0.01% |
7,071,805
-355,361
| -5% | -$3.9M |
|
2171
Relay Therapeutics
RLAY
$4.37B
| $81.3M | ﹤0.01% |
9,796,210
+222,787
| +2% | +$2.17M |
|
2172
QCR Holdings
QCRH
$1.75B
| $81.3M | ﹤0.01% |
1,337,796
-65,798
| -5% | -$3.77M |
|
2173
Alkami Technology
ALKT
$2.22B
| $80.8M | ﹤0.01% |
3,288,143
-15,616
| -0.5% | -$383K |
|
2174
Corsair Gaming
CRSR
$1.45B
| $80.6M | ﹤0.01% |
6,527,615
-60,576
| -0.9% | -$787K |
|
2175
German American Bancorp
GABC
$1.92B
| $80.4M | ﹤0.01% |
2,320,543
-118,984
| -5% | -$3.85M |
|
Similar funds
BlackRock's Q1 2024 Portfolio in Review
As of Q1 2024, BlackRock held 5,499 positions worth $4.3T, up 9.5% from $3.92T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
BlackRock's Q1 2024 filing shows 129 new, 1,833 increased, 2,801 reduced and 210 closed positions. Its largest new stake was Arcadium Lithium plc: 122,471,992 shares worth $528M. The largest sale was iShares Core S&P 500 ETF, an estimated $2.53B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2024 buy was Arcadium Lithium plc: 122,471,992 shares worth $528M.
- BlackRock added most to Microsoft in Q1 2024, an estimated $2.87B increase.
- BlackRock's biggest Q1 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.53B.
- BlackRock fully exited Splunk Inc in Q1 2024, selling an estimated $1.81B.
- BlackRock's ten largest holdings make up 24% of its $4.3T portfolio in Q1 2024.
- BlackRock opened 129 new positions and closed 210 in Q1 2024.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $4.3T.
Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.